Primus Pharmaceuticals was launched in 2001 to fill a growing market need with the creation and distribution of safer, natural treatment and prevention options for osteoarthritis and other chronic, age-related conditions. But rather than introduce a new pharmaceutical drug or dietary supplement to accomplish this goal, Primus took a less-traveled path into the realm of medical foods — a regulatory class of products defined by the Orphan Drug Act Amendment of 1988 as specially formulate
All access premium subscription
This content requires a subscription to Nutrition Business Journal.
As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on newhope.com (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.
Email [email protected] for more information about subscribing.